img

Global Medical Cannabis Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Medical Cannabis Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Medicinal cannabis are also known as Medical marijuana, which area used either to treat disease or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures.
The global Medical Cannabis market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The various economies are involved in the activities to legalize the export of medicinal cannabis product, which in turn is expected to fuel growth of the medical cannabis market.
In terms of sales (consumption) side, this report focuses on the sales of Medical Cannabis by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Medical Cannabis market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Medical Cannabis market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


BOL Pharma
Tilray
Medreleaf Corporation
Aurora Cannabis, Inc
Canopy Growth Corporation
Insys Therapeutics, Inc
Aphria, Inc
MGC Pharmaceuticals Limited
GW Pharmaceuticals, plc
Medical Marijuana Inc
Medipharm Labs
By Type
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
By Application
Pain
Arthritis
Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Medical Cannabis in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Medical Cannabis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Cannabis sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Medical Cannabis Definition
1.2 Market by Type
1.2.1 Global Medical Cannabis Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Tetrahydrocannabinol (THC)
1.2.3 Cannabidiol (CBD)
1.3 Market Segment by Application
1.3.1 Global Medical Cannabis Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Pain
1.3.3 Arthritis
1.3.4 Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Medical Cannabis Sales
2.1 Global Medical Cannabis Revenue Estimates and Forecasts 2018-2034
2.2 Global Medical Cannabis Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Medical Cannabis Revenue by Region
2.3.1 Global Medical Cannabis Revenue by Region (2018-2024)
2.3.2 Global Medical Cannabis Revenue by Region (2024-2034)
2.4 Global Medical Cannabis Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Medical Cannabis Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Medical Cannabis Sales Quantity by Region
2.6.1 Global Medical Cannabis Sales Quantity by Region (2018-2024)
2.6.2 Global Medical Cannabis Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Medical Cannabis Sales Quantity by Manufacturers
3.1.1 Global Medical Cannabis Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Medical Cannabis Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Medical Cannabis Sales in 2022
3.2 Global Medical Cannabis Revenue by Manufacturers
3.2.1 Global Medical Cannabis Revenue by Manufacturers (2018-2024)
3.2.2 Global Medical Cannabis Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Medical Cannabis Revenue in 2022
3.3 Global Medical Cannabis Sales Price by Manufacturers
3.4 Global Key Players of Medical Cannabis, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Medical Cannabis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Medical Cannabis, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Medical Cannabis, Product Offered and Application
3.8 Global Key Manufacturers of Medical Cannabis, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Medical Cannabis Sales Quantity by Type
4.1.1 Global Medical Cannabis Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Medical Cannabis Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Medical Cannabis Sales Quantity Market Share by Type (2018-2034)
4.2 Global Medical Cannabis Revenue by Type
4.2.1 Global Medical Cannabis Historical Revenue by Type (2018-2024)
4.2.2 Global Medical Cannabis Forecasted Revenue by Type (2024-2034)
4.2.3 Global Medical Cannabis Revenue Market Share by Type (2018-2034)
4.3 Global Medical Cannabis Price by Type
4.3.1 Global Medical Cannabis Price by Type (2018-2024)
4.3.2 Global Medical Cannabis Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Medical Cannabis Sales Quantity by Application
5.1.1 Global Medical Cannabis Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Medical Cannabis Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Medical Cannabis Sales Quantity Market Share by Application (2018-2034)
5.2 Global Medical Cannabis Revenue by Application
5.2.1 Global Medical Cannabis Historical Revenue by Application (2018-2024)
5.2.2 Global Medical Cannabis Forecasted Revenue by Application (2024-2034)
5.2.3 Global Medical Cannabis Revenue Market Share by Application (2018-2034)
5.3 Global Medical Cannabis Price by Application
5.3.1 Global Medical Cannabis Price by Application (2018-2024)
5.3.2 Global Medical Cannabis Price Forecast by Application (2024-2034)
6 North America
6.1 North America Medical Cannabis Sales by Company
6.1.1 North America Medical Cannabis Revenue by Company (2018-2024)
6.1.2 North America Medical Cannabis Sales Quantity by Company (2018-2024)
6.2 North America Medical Cannabis Market Size by Type
6.2.1 North America Medical Cannabis Sales Quantity by Type (2018-2034)
6.2.2 North America Medical Cannabis Revenue by Type (2018-2034)
6.3 North America Medical Cannabis Market Size by Application
6.3.1 North America Medical Cannabis Sales Quantity by Application (2018-2034)
6.3.2 North America Medical Cannabis Revenue by Application (2018-2034)
6.4 North America Medical Cannabis Market Size by Country
6.4.1 North America Medical Cannabis Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Medical Cannabis Revenue by Country (2018-2034)
6.4.3 North America Medical Cannabis Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Medical Cannabis Sales by Company
7.1.1 Europe Medical Cannabis Sales Quantity by Company (2018-2024)
7.1.2 Europe Medical Cannabis Revenue by Company (2018-2024)
7.2 Europe Medical Cannabis Market Size by Type
7.2.1 Europe Medical Cannabis Sales Quantity by Type (2018-2034)
7.2.2 Europe Medical Cannabis Revenue by Type (2018-2034)
7.3 Europe Medical Cannabis Market Size by Application
7.3.1 Europe Medical Cannabis Sales Quantity by Application (2018-2034)
7.3.2 Europe Medical Cannabis Revenue by Application (2018-2034)
7.4 Europe Medical Cannabis Market Size by Country
7.4.1 Europe Medical Cannabis Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Medical Cannabis Revenue by Country (2018-2034)
7.4.3 Europe Medical Cannabis Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Medical Cannabis Sales by Company
8.1.1 China Medical Cannabis Sales Quantity by Company (2018-2024)
8.1.2 China Medical Cannabis Revenue by Company (2018-2024)
8.2 China Medical Cannabis Market Size by Type
8.2.1 China Medical Cannabis Sales Quantity by Type (2018-2034)
8.2.2 China Medical Cannabis Revenue by Type (2018-2034)
8.3 China Medical Cannabis Market Size by Application
8.3.1 China Medical Cannabis Sales Quantity by Application (2018-2034)
8.3.2 China Medical Cannabis Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Medical Cannabis Sales by Company
9.1.1 APAC Medical Cannabis Sales Quantity by Company (2018-2024)
9.1.2 APAC Medical Cannabis Revenue by Company (2018-2024)
9.2 APAC Medical Cannabis Market Size by Type
9.2.1 APAC Medical Cannabis Sales Quantity by Type (2018-2034)
9.2.2 APAC Medical Cannabis Revenue by Type (2018-2034)
9.3 APAC Medical Cannabis Market Size by Application
9.3.1 APAC Medical Cannabis Sales Quantity by Application (2018-2034)
9.3.2 APAC Medical Cannabis Revenue by Application (2018-2034)
9.4 APAC Medical Cannabis Market Size by Region
9.4.1 APAC Medical Cannabis Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Medical Cannabis Revenue by Region (2018-2034)
9.4.3 APAC Medical Cannabis Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Medical Cannabis Sales by Company
10.1.1 Middle East, Africa and Latin America Medical Cannabis Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Medical Cannabis Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Medical Cannabis Market Size by Type
10.2.1 Middle East, Africa and Latin America Medical Cannabis Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Medical Cannabis Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Medical Cannabis Market Size by Application
10.3.1 Middle East, Africa and Latin America Medical Cannabis Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Medical Cannabis Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Medical Cannabis Market Size by Country
10.4.1 Middle East, Africa and Latin America Medical Cannabis Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Medical Cannabis Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Medical Cannabis Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 BOL Pharma
11.1.1 BOL Pharma Company Information
11.1.2 BOL Pharma Overview
11.1.3 BOL Pharma Medical Cannabis Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 BOL Pharma Medical Cannabis Products and Services
11.1.5 BOL Pharma Medical Cannabis SWOT Analysis
11.1.6 BOL Pharma Recent Developments
11.2 Tilray
11.2.1 Tilray Company Information
11.2.2 Tilray Overview
11.2.3 Tilray Medical Cannabis Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Tilray Medical Cannabis Products and Services
11.2.5 Tilray Medical Cannabis SWOT Analysis
11.2.6 Tilray Recent Developments
11.3 Medreleaf Corporation
11.3.1 Medreleaf Corporation Company Information
11.3.2 Medreleaf Corporation Overview
11.3.3 Medreleaf Corporation Medical Cannabis Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Medreleaf Corporation Medical Cannabis Products and Services
11.3.5 Medreleaf Corporation Medical Cannabis SWOT Analysis
11.3.6 Medreleaf Corporation Recent Developments
11.4 Aurora Cannabis, Inc
11.4.1 Aurora Cannabis, Inc Company Information
11.4.2 Aurora Cannabis, Inc Overview
11.4.3 Aurora Cannabis, Inc Medical Cannabis Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Aurora Cannabis, Inc Medical Cannabis Products and Services
11.4.5 Aurora Cannabis, Inc Medical Cannabis SWOT Analysis
11.4.6 Aurora Cannabis, Inc Recent Developments
11.5 Canopy Growth Corporation
11.5.1 Canopy Growth Corporation Company Information
11.5.2 Canopy Growth Corporation Overview
11.5.3 Canopy Growth Corporation Medical Cannabis Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Canopy Growth Corporation Medical Cannabis Products and Services
11.5.5 Canopy Growth Corporation Medical Cannabis SWOT Analysis
11.5.6 Canopy Growth Corporation Recent Developments
11.6 Insys Therapeutics, Inc
11.6.1 Insys Therapeutics, Inc Company Information
11.6.2 Insys Therapeutics, Inc Overview
11.6.3 Insys Therapeutics, Inc Medical Cannabis Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Insys Therapeutics, Inc Medical Cannabis Products and Services
11.6.5 Insys Therapeutics, Inc Medical Cannabis SWOT Analysis
11.6.6 Insys Therapeutics, Inc Recent Developments
11.7 Aphria, Inc
11.7.1 Aphria, Inc Company Information
11.7.2 Aphria, Inc Overview
11.7.3 Aphria, Inc Medical Cannabis Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Aphria, Inc Medical Cannabis Products and Services
11.7.5 Aphria, Inc Medical Cannabis SWOT Analysis
11.7.6 Aphria, Inc Recent Developments
11.8 MGC Pharmaceuticals Limited
11.8.1 MGC Pharmaceuticals Limited Company Information
11.8.2 MGC Pharmaceuticals Limited Overview
11.8.3 MGC Pharmaceuticals Limited Medical Cannabis Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 MGC Pharmaceuticals Limited Medical Cannabis Products and Services
11.8.5 MGC Pharmaceuticals Limited Medical Cannabis SWOT Analysis
11.8.6 MGC Pharmaceuticals Limited Recent Developments
11.9 GW Pharmaceuticals, plc
11.9.1 GW Pharmaceuticals, plc Company Information
11.9.2 GW Pharmaceuticals, plc Overview
11.9.3 GW Pharmaceuticals, plc Medical Cannabis Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 GW Pharmaceuticals, plc Medical Cannabis Products and Services
11.9.5 GW Pharmaceuticals, plc Medical Cannabis SWOT Analysis
11.9.6 GW Pharmaceuticals, plc Recent Developments
11.10 Medical Marijuana Inc
11.10.1 Medical Marijuana Inc Company Information
11.10.2 Medical Marijuana Inc Overview
11.10.3 Medical Marijuana Inc Medical Cannabis Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Medical Marijuana Inc Medical Cannabis Products and Services
11.10.5 Medical Marijuana Inc Medical Cannabis SWOT Analysis
11.10.6 Medical Marijuana Inc Recent Developments
11.11 Medipharm Labs
11.11.1 Medipharm Labs Company Information
11.11.2 Medipharm Labs Overview
11.11.3 Medipharm Labs Medical Cannabis Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Medipharm Labs Medical Cannabis Products and Services
11.11.5 Medipharm Labs Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Medical Cannabis Value Chain Analysis
12.2 Medical Cannabis Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Medical Cannabis Production Mode & Process
12.4 Medical Cannabis Sales and Marketing
12.4.1 Medical Cannabis Sales Channels
12.4.2 Medical Cannabis Distributors
12.5 Medical Cannabis Customers
13 Market Dynamics
13.1 Medical Cannabis Industry Trends
13.2 Medical Cannabis Market Drivers
13.3 Medical Cannabis Market Challenges
13.4 Medical Cannabis Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Medical Cannabis Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Tetrahydrocannabinol (THC)
Table 3. Major Manufacturers of Cannabidiol (CBD)
Table 4. Global Medical Cannabis Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Medical Cannabis Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Medical Cannabis Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Medical Cannabis Revenue Market Share by Region (2018-2024)
Table 8. Global Medical Cannabis Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Medical Cannabis Revenue Market Share by Region (2024-2034)
Table 10. Global Medical Cannabis Sales Quantity by Region: 2018 VS 2022 VS 2034 (MT)
Table 11. Global Medical Cannabis Sales by Region (2018-2024) & (MT)
Table 12. Global Medical Cannabis Sales Market Share by Region (2018-2024)
Table 13. Global Medical Cannabis Sales by Region (2024-2034) & (MT)
Table 14. Global Medical Cannabis Sales Market Share by Region (2024-2034)
Table 15. Global Medical Cannabis Sales Quantity by Manufacturers (2018-2024) & (MT)
Table 16. Global Medical Cannabis Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Medical Cannabis Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Medical Cannabis Revenue Share by Manufacturers (2018-2024)
Table 19. Global Medical Cannabis Price by Manufacturers 2018-2024 (USD/MT)
Table 20. Global Key Players of Medical Cannabis, Industry Ranking, 2021 VS 2022
Table 21. Global Medical Cannabis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Medical Cannabis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Cannabis as of 2022)
Table 23. Global Key Manufacturers of Medical Cannabis, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Medical Cannabis, Product Offered and Application
Table 25. Global Key Manufacturers of Medical Cannabis, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Medical Cannabis Sales Quantity by Type (2018-2024) & (MT)
Table 28. Global Medical Cannabis Sales Quantity by Type (2024-2034) & (MT)
Table 29. Global Medical Cannabis Sales Quantity Share by Type (2018-2024)
Table 30. Global Medical Cannabis Sales Quantity Share by Type (2024-2034)
Table 31. Global Medical Cannabis Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Medical Cannabis Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Medical Cannabis Revenue Share by Type (2018-2024)
Table 34. Global Medical Cannabis Revenue Share by Type (2024-2034)
Table 35. Medical Cannabis Price by Type (2018-2024) & (USD/MT)
Table 36. Global Medical Cannabis Price Forecast by Type (2024-2034) & (USD/MT)
Table 37. Global Medical Cannabis Sales Quantity by Application (2018-2024) & (MT)
Table 38. Global Medical Cannabis Sales Quantity by Application (2024-2034) & (MT)
Table 39. Global Medical Cannabis Sales Quantity Share by Application (2018-2024)
Table 40. Global Medical Cannabis Sales Quantity Share by Application (2024-2034)
Table 41. Global Medical Cannabis Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Medical Cannabis Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Medical Cannabis Revenue Share by Application (2018-2024)
Table 44. Global Medical Cannabis Revenue Share by Application (2024-2034)
Table 45. Medical Cannabis Price by Application (2018-2024) & (USD/MT)
Table 46. Global Medical Cannabis Price Forecast by Application (2024-2034) & (USD/MT)
Table 47. North America Medical Cannabis Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Medical Cannabis Sales Quantity by Company (2018-2024) & (MT)
Table 49. North America Medical Cannabis Sales Quantity by Type (2018-2024) & (MT)
Table 50. North America Medical Cannabis Sales Quantity by Type (2024-2034) & (MT)
Table 51. North America Medical Cannabis Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Medical Cannabis Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Medical Cannabis Sales Quantity by Application (2018-2024) & (MT)
Table 54. North America Medical Cannabis Sales Quantity by Application (2024-2034) & (MT)
Table 55. North America Medical Cannabis Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Medical Cannabis Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Medical Cannabis Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Medical Cannabis Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Medical Cannabis Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Medical Cannabis Sales Quantity by Country (2018-2024) & (MT)
Table 61. North America Medical Cannabis Sales Quantity by Country (2024-2034) & (MT)
Table 62. Europe Medical Cannabis Sales Quantity by Company (2018-2024) & (MT)
Table 63. Europe Medical Cannabis Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Medical Cannabis Sales Quantity by Type (2018-2024) & (MT)
Table 65. Europe Medical Cannabis Sales Quantity by Type (2024-2034) & (MT)
Table 66. Europe Medical Cannabis Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Medical Cannabis Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Medical Cannabis Sales Quantity by Application (2018-2024) & (MT)
Table 69. Europe Medical Cannabis Sales Quantity by Application (2024-2034) & (MT)
Table 70. Europe Medical Cannabis Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Medical Cannabis Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Medical Cannabis Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Medical Cannabis Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Medical Cannabis Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Medical Cannabis Sales Quantity by Country (2018-2024) & (MT)
Table 76. Europe Medical Cannabis Sales Quantity by Country (2024-2034) & (MT)
Table 77. China Medical Cannabis Sales Quantity by Company (2018-2024) & (MT)
Table 78. China Medical Cannabis Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Medical Cannabis Sales Quantity by Type (2018-2024) & (MT)
Table 80. China Medical Cannabis Sales Quantity by Type (2024-2034) & (MT)
Table 81. China Medical Cannabis Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Medical Cannabis Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Medical Cannabis Sales Quantity by Application (2018-2024) & (MT)
Table 84. China Medical Cannabis Sales Quantity by Application (2024-2034) & (MT)
Table 85. China Medical Cannabis Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Medical Cannabis Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Medical Cannabis Sales Quantity by Company (2018-2024) & (MT)
Table 88. APAC Medical Cannabis Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Medical Cannabis Sales Quantity by Type (2018-2024) & (MT)
Table 90. APAC Medical Cannabis Sales Quantity by Type (2024-2034) & (MT)
Table 91. APAC Medical Cannabis Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Medical Cannabis Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Medical Cannabis Sales Quantity by Application (2018-2024) & (MT)
Table 94. APAC Medical Cannabis Sales Quantity by Application (2024-2034) & (MT)
Table 95. APAC Medical Cannabis Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Medical Cannabis Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Medical Cannabis Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Medical Cannabis Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Medical Cannabis Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Medical Cannabis Sales Quantity by Region (2018-2024) & (MT)
Table 101. APAC Medical Cannabis Sales Quantity by Region (2024-2034) & (MT)
Table 102. Middle East, Africa and Latin America Medical Cannabis Sales Quantity by Company (2018-2024) & (MT)
Table 103. Middle East, Africa and Latin America Medical Cannabis Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Medical Cannabis Sales Quantity by Type (2018-2024) & (MT)
Table 105. Middle East, Africa and Latin America Medical Cannabis Sales Quantity by Type (2024-2034) & (MT)
Table 106. Middle East, Africa and Latin America Medical Cannabis Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Medical Cannabis Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Medical Cannabis Sales Quantity by Application (2018-2024) & (MT)
Table 109. Middle East, Africa and Latin America Medical Cannabis Sales Quantity by Application (2024-2034) & (MT)
Table 110. Middle East, Africa and Latin America Medical Cannabis Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Medical Cannabis Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Medical Cannabis Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Medical Cannabis Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Medical Cannabis Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Medical Cannabis Sales Quantity by Country (2018-2024) & (MT)
Table 116. Middle East, Africa and Latin America Medical Cannabis Sales Quantity by Country (2024-2034) & (MT)
Table 117. BOL Pharma Company Information
Table 118. BOL Pharma Description and Overview
Table 119. BOL Pharma Medical Cannabis Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 120. BOL Pharma Medical Cannabis Product and Services
Table 121. BOL Pharma Medical Cannabis SWOT Analysis
Table 122. BOL Pharma Recent Developments
Table 123. Tilray Company Information
Table 124. Tilray Description and Overview
Table 125. Tilray Medical Cannabis Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 126. Tilray Medical Cannabis Product and Services
Table 127. Tilray Medical Cannabis SWOT Analysis
Table 128. Tilray Recent Developments
Table 129. Medreleaf Corporation Company Information
Table 130. Medreleaf Corporation Description and Overview
Table 131. Medreleaf Corporation Medical Cannabis Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 132. Medreleaf Corporation Medical Cannabis Product and Services
Table 133. Medreleaf Corporation Medical Cannabis SWOT Analysis
Table 134. Medreleaf Corporation Recent Developments
Table 135. Aurora Cannabis, Inc Company Information
Table 136. Aurora Cannabis, Inc Description and Overview
Table 137. Aurora Cannabis, Inc Medical Cannabis Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 138. Aurora Cannabis, Inc Medical Cannabis Product and Services
Table 139. Aurora Cannabis, Inc Medical Cannabis SWOT Analysis
Table 140. Aurora Cannabis, Inc Recent Developments
Table 141. Canopy Growth Corporation Company Information
Table 142. Canopy Growth Corporation Description and Overview
Table 143. Canopy Growth Corporation Medical Cannabis Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 144. Canopy Growth Corporation Medical Cannabis Product and Services
Table 145. Canopy Growth Corporation Medical Cannabis SWOT Analysis
Table 146. Canopy Growth Corporation Recent Developments
Table 147. Insys Therapeutics, Inc Company Information
Table 148. Insys Therapeutics, Inc Description and Overview
Table 149. Insys Therapeutics, Inc Medical Cannabis Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 150. Insys Therapeutics, Inc Medical Cannabis Product and Services
Table 151. Insys Therapeutics, Inc Medical Cannabis SWOT Analysis
Table 152. Insys Therapeutics, Inc Recent Developments
Table 153. Aphria, Inc Company Information
Table 154. Aphria, Inc Description and Overview
Table 155. Aphria, Inc Medical Cannabis Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 156. Aphria, Inc Medical Cannabis Product and Services
Table 157. Aphria, Inc Medical Cannabis SWOT Analysis
Table 158. Aphria, Inc Recent Developments
Table 159. MGC Pharmaceuticals Limited Company Information
Table 160. MGC Pharmaceuticals Limited Description and Overview
Table 161. MGC Pharmaceuticals Limited Medical Cannabis Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 162. MGC Pharmaceuticals Limited Medical Cannabis Product and Services
Table 163. MGC Pharmaceuticals Limited Medical Cannabis SWOT Analysis
Table 164. MGC Pharmaceuticals Limited Recent Developments
Table 165. GW Pharmaceuticals, plc Company Information
Table 166. GW Pharmaceuticals, plc Description and Overview
Table 167. GW Pharmaceuticals, plc Medical Cannabis Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 168. GW Pharmaceuticals, plc Medical Cannabis Product and Services
Table 169. GW Pharmaceuticals, plc Medical Cannabis SWOT Analysis
Table 170. GW Pharmaceuticals, plc Recent Developments
Table 171. Medical Marijuana Inc Company Information
Table 172. Medical Marijuana Inc Description and Overview
Table 173. Medical Marijuana Inc Medical Cannabis Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 174. Medical Marijuana Inc Medical Cannabis Product and Services
Table 175. Medical Marijuana Inc Medical Cannabis SWOT Analysis
Table 176. Medical Marijuana Inc Recent Developments
Table 177. Medipharm Labs Company Information
Table 178. Medipharm Labs Description and Overview
Table 179. Medipharm Labs Medical Cannabis Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 180. Medipharm Labs Medical Cannabis Product and Services
Table 181. Medipharm Labs Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Medical Cannabis Distributors List
Table 185. Medical Cannabis Customers List
Table 186. Medical Cannabis Market Trends
Table 187. Medical Cannabis Market Drivers
Table 188. Medical Cannabis Market Challenges
Table 189. Medical Cannabis Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Cannabis Product Picture
Figure 2. Global Medical Cannabis Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Medical Cannabis Market Share by Type in 2022 & 2034
Figure 4. Tetrahydrocannabinol (THC) Product Picture
Figure 5. Cannabidiol (CBD) Product Picture
Figure 6. Global Medical Cannabis Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Medical Cannabis Market Share by Application in 2022 & 2034
Figure 8. Pain
Figure 9. Arthritis
Figure 10. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
Figure 11. Others
Figure 12. Medical Cannabis Report Years Considered
Figure 13. Global Medical Cannabis Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Medical Cannabis Revenue 2018-2034 (US$ Million)
Figure 15. Global Medical Cannabis Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Medical Cannabis Sales Quantity 2018-2034 (MT)
Figure 17. Global Medical Cannabis Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Medical Cannabis Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Medical Cannabis Sales Quantity YoY (2018-2034) & (MT)
Figure 20. North America Medical Cannabis Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Medical Cannabis Sales Quantity YoY (2018-2034) & (MT)
Figure 22. Europe Medical Cannabis Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Medical Cannabis Sales Quantity YoY (2018-2034) & (MT)
Figure 24. China Medical Cannabis Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Medical Cannabis Sales Quantity YoY (2018-2034) & (MT)
Figure 26. APAC Medical Cannabis Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Medical Cannabis Sales Quantity YoY (2018-2034) & (MT)
Figure 28. Middle East, Africa and Latin America Medical Cannabis Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Medical Cannabis Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by Medical Cannabis Revenue in 2022
Figure 31. Medical Cannabis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Medical Cannabis Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Medical Cannabis Revenue Market Share by Type (2018-2034)
Figure 34. Global Medical Cannabis Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Medical Cannabis Revenue Market Share by Application (2018-2034)
Figure 36. North America Medical Cannabis Revenue Market Share by Company in 2022
Figure 37. North America Medical Cannabis Sales Quantity Market Share by Company in 2022
Figure 38. North America Medical Cannabis Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Medical Cannabis Revenue Market Share by Type (2018-2034)
Figure 40. North America Medical Cannabis Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Medical Cannabis Revenue Market Share by Application (2018-2034)
Figure 42. North America Medical Cannabis Revenue Share by Country (2018-2034)
Figure 43. North America Medical Cannabis Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Medical Cannabis Sales Quantity Market Share by Company in 2022
Figure 47. Europe Medical Cannabis Revenue Market Share by Company in 2022
Figure 48. Europe Medical Cannabis Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Medical Cannabis Revenue Market Share by Type (2018-2034)
Figure 50. Europe Medical Cannabis Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Medical Cannabis Revenue Market Share by Application (2018-2034)
Figure 52. Europe Medical Cannabis Revenue Share by Country (2018-2034)
Figure 53. Europe Medical Cannabis Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 55. France Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 59. China Medical Cannabis Sales Quantity Market Share by Company in 2022
Figure 60. China Medical Cannabis Revenue Market Share by Company in 2022
Figure 61. China Medical Cannabis Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Medical Cannabis Revenue Market Share by Type (2018-2034)
Figure 63. China Medical Cannabis Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Medical Cannabis Revenue Market Share by Application (2018-2034)
Figure 65. APAC Medical Cannabis Sales Quantity Market Share by Company in 2022
Figure 66. APAC Medical Cannabis Revenue Market Share by Company in 2022
Figure 67. APAC Medical Cannabis Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Medical Cannabis Revenue Market Share by Type (2018-2034)
Figure 69. APAC Medical Cannabis Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Medical Cannabis Revenue Market Share by Application (2018-2034)
Figure 71. APAC Medical Cannabis Revenue Share by Region (2018-2034)
Figure 72. APAC Medical Cannabis Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 77. India Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Medical Cannabis Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Medical Cannabis Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Medical Cannabis Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Medical Cannabis Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Medical Cannabis Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Medical Cannabis Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Medical Cannabis Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Medical Cannabis Revenue Share by Country (2018-2034)
Figure 86. Brazil Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Medical Cannabis Revenue (2018-2034) & (US$ Million)
Figure 91. Medical Cannabis Value Chain
Figure 92. Medical Cannabis Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed